A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region

Clinical trial NCT07710664 · RECRUITING

Trial details

NCT number: NCT07710664
Sponsor: Newish Biotech (Wuxi) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Persistent HPV16 Infection

Start date: 2026-07-20
Primary completion: 2026-12-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.